Ignite Creation Date:
2024-05-06 @ 1:33 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04054791
Status:
COMPLETED
Last Update Posted:
2019-08-13
First Post:
2019-08-08
Brief Title:
Endonasal Dacryocystorhinostomy and Evolution of the Stoma Size
Sponsor:
Centre Hospitalier Régional Metz-Thionville
Organization:
Centre Hospitalier Régional Metz-Thionville
Study Overview
Official Title:
Endonasal Dacryocystorhinostomy Prospective Study of the Evolution of the Stoma Size
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EndoDCRevol
Brief Summary:
Dacryocystorhinostomy DCR is a procedure of choice for nasolacrimal duct obstruction Endonasal procedures for DCR were described as early as 1893 by Caldwell However external DCR was practiced more commonly because of better visualization of anatomic features The miniaturization of surgical instruments and close partnership between ophthalmologist and otorhinolaryngologist had led to a renewal of endonasal approach
The main objective of the study is to show the evolution of stoma size after endonasal DCR and validate the direct measurement of mucous orifice It will also allow determining if the stoma evolution size may be a predictive factor for operational effectiveness
The main objective of the study is to show the evolution of stoma size after endonasal DCR and validate the direct measurement of mucous orifice It will also allow determining if the stoma evolution size may be a predictive factor for operational effectiveness
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None